Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Athenex, Inc. | Pres Cell Therapy, VP Corp Dev | Common Stock | 81.6K | $111K | $1.36 | Sep 16, 2022 | Direct |
Athenex, Inc. | Pres Cell Therapy, VP Corp Dev | Stock Option (Right to Buy) | 200K | Sep 16, 2022 | Direct | ||
Athenex, Inc. | Pres Cell Therapy, VP Corp Dev | Restricted Stock Units | 37.5K | Sep 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATNXQ | Athenex, Inc. | Sep 16, 2022 | 3 | -$1.77K | 4 | Sep 19, 2022 | Pres Cell Therapy, VP Corp Dev |
ATNXQ | Athenex, Inc. | Jul 20, 2022 | 1 | $0 | 4 | Jul 21, 2022 | Pres Cell Therapy, VP Corp Dev |
ATNXQ | Athenex, Inc. | Nov 22, 2021 | 0 | $0 | 3 | Dec 1, 2021 | Pres Cell Therapy, VP Corp Dev |